KUALA LUMPUR, June 30 (Bernama) -- Curia, a contract research, development and manufacturing organisation, announced it has been awarded a Best Practices Customer Value Leadership Award in the CRDMO industry by Frost & Sullivan.
“We are very honoured to be recognised with this award, which underlines the hard work and dedication of all of our employees to delivering quality and reliability when serving our customers.
“We remain steadfast in our noble purpose of improving patients’ lives, a mission that begins with our commitment to creating value for our customers,” said Curia Chief Executive Officer, Philip Macnabb in a statement.
Frost & Sullivan noted in its report that the company’s rebrand from AMRI to Curia in 2021 put a focus on science at the centre of its brand identity, highlighting a pledge to help customers advance “from curiosity to cure”.
Curia has evolved over time to offer a comprehensive range of services from drug discovery through development to manufacture of both drug substance and drug product for pharmaceutical and biologics companies.
The award recognises how Curia seeks out innovative solutions by using the latest technologies to efficiently move products from discovery to development to commercial scale to accelerate speed to market for its customers.
Each year, Frost & Sullivan employs a rigorous evaluation, measuring business and customer impact, to identify companies that consistently innovate to meet their customers’ needs while navigating new challenges and opportunities.
The winner is recognised for providing a superior customer experience for overall price, performance and quality.
-- BERNAMA
No comments:
Post a Comment